The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation

Supportive Care in Cancer

Volumn 7, Issue 2, 1999, Pages 79-83

  Barbounis, Vassilis ^a   Koumakis, George ^a   Hatzichristou, Helen ^a   Vassilomanolakis, Michael ^a   Tsoussis, Sofocles ^a   Efremidis, Anna ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

5HT3 antagonists; Bone marrow transplantation; Dexamethasone; Emesis; Tropisetron

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; PACLITAXEL; SEROTONIN 2 ANTAGONIST; TROPISETRON;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; OVARY CANCER; PRIORITY JOURNAL; VOMITING;

ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CONSTIPATION; DEXAMETHASONE; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDOLES; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; SEROTONIN ANTAGONISTS; TRANSPLANTATION CONDITIONING; VOMITING;

EID: 0033061918     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050231     Document Type: Article

References (23)

1. Koura T, Itoh T, Motimary J, Inone M, Horikoshi A, Ohshima T, Hayashi I, Tani M, Fujii M, Horie T (1995) Rectus hematoma secondary to vomiting: a complication of conditioning regimen for bone marrow transplantation. Intern Med 34:39-41
2. Kris MG, Gralla RJ, Tyson LB, Clark RA, Kelsen DP (1985) Improved control of cisplatin induced emesis with high dose metoclopramide and combinations of metoclopramide, dexamethasone and diphenhydramine. Cancer 55:527-534
3. Kris MG, Gralla RJ, Clark RA, Tyson LB, Groshen S (1987) Antiemetic control and prevention of side effects of anticancer therapy with lorazepam when used in combination with metoclopramide and dexamethasone. Cancer 60:2816-2822
4. Roila F, Tonato M, Basurto C, Bella M, Passalacqua R, Morsia DD, Costanzo F, Donati D, Ballaori E, Tognoni G, Franzosi MG, Del Favero A, (1987) Antiemetic activity of high dose of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients. J Clin Oncol 5:141-149
5. 3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Support Care Cancer 6:237-243
6. Verweij J, de Wit R, de Mulder PHM (1996) Optimal control of acute cisplatin induced emesis. Oncology 53 [Suppl 1]:56-64
7. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (1998) Prevention of chemotherapy and radiotherapy induced emesis: Results of the Perugia Consensus Conference. Ann Oncol 9:811-819
8. Spitzer TR, Cirenza E, McAfee S, Foelber R, Zarzond, Cahill R, Mazumder A (1995) Phase I-II trial of high dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue. Bone Marrow Transplant 15:4, 537-542
9. Lee CR, Plosker GL, McTavish D (1993) Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential as an antiemetic. Drugs 46:925-943
10. Yen CC, Hsieh RK, Chiou TJ, Lin JH, Fang FS, Wang WS, Tung SL, Tzeng CH, Chen PM (1998) Navoban and dexamethasone combination in the prevention of vomiting for patients receiving preconditioning high dose chemotherapy before marrow transplantation. Jpn J Clin Oncol 28:129-133
11. Drechsler S, Bruntsch U, Eggert J, Grotekiehn J, Gosse H, Bangerter M, Ukena D, Oehm C, Merger J, Faerber L, Imhoft W, Untch M, Gallmeier WM (1997) Comparison of three tropisetron containing regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea. Support Care Cancer 5:387-395
12. Roila F (1995) Dexamethasone, granisetron or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-6
13. Bosi A, Guidi S, Messori A, Saccardi R, Lombardini L, Vannucchi AM, Fanci R, Rossi-Ferrini P (1993) Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study. J Chemother 5:191-196
14. Ocamoto S, Takahashi S, Tanosaki R, Sakamaki H, Onozawa Y, Oh H, Miyawaki S, Kinura Y, Toyama K, Ikeda Y, Asano A (1996) Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Bone Marrow Transplant 17:679-683
15. Or R, Dracos P, Nagler A, Naparstek E, Kapelushni KJ, Cass Y, (1994) The antiemetic efficacy and tolerability of tropisetron in patients conditioned with high dose chemotherapy with and without total body irradiation prior to bone marrow transplantation. Support Care Cancer 2:245-248
16. Barbounis V, Koumakis G, Vassilomanolakis M, Hatzichristou H, Tsoussis S, Efremidis AP (1995) A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation. Support Care Cancer 3:301-306
17. 3 antagonist. Bone Marrow Transplant 7:431-433
18. Bregni M, Sienna S, Di Nicola M, Bonadonna G, Gianni AM, (1991) Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. Eur J Cancer 27:561-565
19. Gilbert JC, Ohly KV, Rosner G, Peters WP (1995) Randomised, double-blind comparison of a prochloperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. Cancer 76:233-237
20. Gralla RJ, Rittenberg C, Peralta M, Lettow L, Cronin M (1996) Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 hours after cisplatin. Oncology 53 [Suppl 1]:86-91
21. 3 receptor antagonists in the control of cisplatin induced delayed emesis. Oncology 53 [Suppl 1]:78-85
22. Kris MG, Roila F, de Mulder PHM, Marty M (1998) Delayed emesis following anticancer chemotherapy. Support Care Cancer 6:228-232
23. Del Favero A, Roila F, Tonato M (1993) Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities. Drug Saf 9:410-428